Table 2

Effect of inhibition of adenylate cyclase (TFPA) and K+channels (glibenclamide/TBA) on relaxation by CRF

ED50 (log mol)Area Under Curve (arbitrary unit)
Control−7.01  ± 0.1937.18  ± 14.15
TFPA−7.06  ± 0.1633.39  ± 7.87
Glibenclamide−7.38  ± 0.1749.23  ± 9.60
TBA−7.08  ± 0.1335.20  ± 3.85

One-way analysis of variance followed by Newman–Keuls multiple comparisons test was used, and the means were not significantly different; p > .05.